Amirah Etchegaray

Brisbane, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Letter: Acute Severe Ulcerative Colitis in the Advanced Therapy Era: Is Lowering the CRP Threshold Enough? Authors' Reply.

Letter: Acute Severe Ulcerative Colitis in the Advanced Therapy Era: Is Lowering the CRP Threshold Enough? Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: August 28, 2026

Editorial on: 'Lowering the C-Reactive Protein Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity-Matched Analysis'. Authors' Reply.

Editorial on: 'Lowering the C-Reactive Protein Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity-Matched Analysis'. Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: July 19, 2026

Lowering the C-Reactive Protein (CRP) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity-Matched Analysis.

Lowering the C-Reactive Protein (CRP) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity-Matched Analysis.

Journal: Alimentary pharmacology & therapeutics

Published: March 06, 2026

Endosonographically confirmed type III choledochal cyst managed with endoscopic needle-knife division.

Endosonographically confirmed type III choledochal cyst managed with endoscopic needle-knife division.

Journal: VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy

Published: November 06, 2024

Safety, efficacy and post-endoscopic retrograde cholangiopancreatography survival in nonagenarians: a retrospective cohort study.

Safety, efficacy and post-endoscopic retrograde cholangiopancreatography survival in nonagenarians: a retrospective cohort study.

Journal: Internal medicine journal

Published: October 31, 2024

Sequential rescue therapy with JAK inhibitors in corticosteroid and infliximab-refractory acute severe ulcerative colitis: a case series.

Sequential rescue therapy with JAK inhibitors in corticosteroid and infliximab-refractory acute severe ulcerative colitis: a case series.

Journal: Therapeutic advances in gastroenterology

Published: October 30, 2024

The Durability of Anti-TNF Therapy for Crohn's Disease Is Higher in Anti-TNF Naïve Patients and Increases With Proactive Therapeutic Drug Monitoring.

The Durability of Anti-TNF Therapy for Crohn's Disease Is Higher in Anti-TNF Naïve Patients and Increases With Proactive Therapeutic Drug Monitoring.

Journal: Crohn's & colitis 360

Published: October 28, 2024

Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn's disease.

Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn's disease.

Journal: Intestinal research

Published: October 22, 2024

Showing 1-8 of 8

Last Updated: 09/26/2026